Blood in the Urine
Understanding blood in urine (hematuria) is crucial for accurate clinical documentation and medical coding. This resource provides information on hematuria, including microscopic hematuria and gross hematuria, focusing on diagnosis, healthcare implications, and relevant medical coding terms. Learn about the causes, symptoms, and treatment options for blood in the urine to improve patient care and ensure proper documentation.
Presence of red blood cells in the urine, sometimes visible, sometimes microscopic.
Pink, red, or brown urine; may be painless or associated with pain, clots, or infection symptoms.
Kidney stones, infection (UTI, kidney), enlarged prostate, bladder cancer.
ICD-10 Code Families
Complete code families applicable to R31.9
When to use each related code
| Description | When to use |
|---|---|
| Blood in urine, visible or microscopic. | Use for any presence of blood in urine. Specify type if known (gross/microscopic). |
| Kidney stones obstructing urinary tract. | Use when imaging confirms kidney stones causing urinary obstruction and/or hematuria. |
| Bladder infection causing urinary symptoms. | Use for cystitis with symptoms like dysuria, frequency, urgency, and possible hematuria. |
Best-practice checklist
- ✓Document hematuria type: gross or microscopic.
- ✓Describe urine color, e.g., pink, red, brown.
- ✓Note blood clot presence/absence.
- ✓Document symptom onset, duration, frequency.
- ✓Record related symptoms: pain, dysuria, etc.
Common pitfalls to avoid
Coding for hematuria requires specifying microscopic vs. gross hematuria for accurate reimbursement and clinical documentation integrity.
Failure to code the underlying cause of hematuria leads to inaccurate risk adjustment and incomplete clinical picture.
Distinguishing between traumatic and medical hematuria is crucial for correct coding, impacting quality reporting and resource allocation.
Best-practice tips
- 01Document hematuria etiology: infection, trauma, stones, BPH, meds. ICD-10 R31, N02
- 02Query provider for symptom onset, duration, characteristics (color, clots). CDI best practice
- 03Review medication list for anticoagulants, NSAIDs. Drug-induced hematuria? RxNorm
- 04Order urinalysis, urine culture, imaging (CT, ultrasound) per guidelines. HCC coding
- 05Consider cystoscopy for persistent, unexplained hematuria. Improve clinical documentation
Step-by-step checklist
- 1
Confirm hematuria: visual or microscopic (ICD-10 R31.9, N02.9)? Document type.
- 2
Assess for urinary tract infection (ICD-10 N39.0): urinalysis, culture.
- 3
Evaluate for kidney stones (ICD-10 N75.0): imaging, pain assessment.
- 4
Consider glomerular diseases (ICD-10 N80-N89): renal function tests.
Ready-to-paste narrative
Patient presents with hematuria, clinically manifesting as blood in the urine. Differential diagnosis includes microscopic hematuria, gross hematuria, urinary tract infection (UTI), kidney stones, bladder cancer, prostate issues (in males), and strenuous exercise. The patient's reported symptoms include [insert patient-reported symptoms, e.g., dysuria, frequency, urgency, flank pain, visible blood in urine]. Physical examination findings include [insert objective findings, e.g., costovertebral angle tenderness, suprapubic tenderness]. Urinalysis results show [insert pertinent urinalysis findings, e.g., positive for red blood cells, presence of proteinuria, leukocyte esterase]. Based on the presenting symptoms, physical examination, and urinalysis, the preliminary diagnosis is hematuria. Further investigation is required to determine the underlying etiology. Ordered tests include [insert ordered tests, e.g., urine culture, CT urogram, cystoscopy, renal ultrasound]. Plan of care includes [insert plan of care, e.g., pain management with analgesics, increased fluid intake, antibiotics if UTI suspected, referral to urology]. Patient education provided on signs and symptoms to monitor, importance of follow-up care, and potential complications of untreated hematuria. ICD-10 code [insert appropriate ICD-10 code, e.g., R31.9, N02.9, N02.0] will be used for billing purposes. CPT codes for the ordered tests and procedures will be documented accordingly. Follow-up scheduled in [duration] to review test results and adjust treatment plan as necessary.
Common questions and answers
What is the most effective differential diagnosis approach for microscopic hematuria in asymptomatic adult patients?+
Microscopic hematuria, defined as 3 or more red blood cells per high-power field on urinalysis, in asymptomatic adults necessitates a thorough, risk-stratified diagnostic approach. Initial assessment should distinguish between glomerular and non-glomerular causes by considering factors like proteinuria, red blood cell casts, and patient history (e.g., autoimmune diseases, nephrotoxic drug use). For low-risk patients (<50 years, no smoking history, no family history of urologic malignancy), repeat urinalysis is crucial. Persistent microscopic hematuria warrants further investigation, potentially including urine cytology and imaging (e.g., renal ultrasound, CT urography). High-risk individuals should undergo immediate imaging and urological evaluation to rule out malignancy. Explore how risk stratification and evidence-based guidelines can enhance your diagnostic accuracy for microscopic hematuria. Consider implementing a standardized protocol for managing asymptomatic microscopic hematuria in your practice.
How can I differentiate between benign and malignant causes of gross hematuria in an elderly patient with a history of smoking?+
Gross hematuria, visible blood in the urine, in an elderly patient with a smoking history raises significant concern for malignancy. While benign causes like urinary tract infections, kidney stones, and benign prostatic hyperplasia can also present with gross hematuria, a malignant etiology (e.g., bladder cancer, renal cell carcinoma) must be promptly excluded. A comprehensive evaluation includes detailed history taking, physical examination, urinalysis, urine cytology, and imaging studies such as CT urography or cystoscopy. Smoking history significantly increases the risk of urothelial carcinoma, making prompt and thorough investigation paramount. The presence of other risk factors, such as occupational exposure to carcinogens or a family history of urological cancers, further strengthens the suspicion for malignancy. Learn more about the latest guidelines for evaluating gross hematuria and the role of risk stratification in guiding clinical decision-making.
When is a referral to a urologist or nephrologist indicated for hematuria evaluation and management?+
Referral to a specialist, either a urologist or nephrologist, depends on the specific clinical scenario and the suspected underlying cause of hematuria. Persistent microscopic hematuria despite a negative initial workup, especially in high-risk patients (e.g., older age, smoking history), warrants urological evaluation. Gross hematuria, regardless of patient risk factors, requires prompt urological assessment. Suspicion of glomerular hematuria based on urinalysis findings (e.g., proteinuria, red blood cell casts) often necessitates nephrology referral. Recurrent or refractory hematuria, even if initially attributed to a benign cause, may benefit from specialist input. Consider implementing clear referral criteria for hematuria to ensure timely and appropriate specialist involvement in patient care.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.